Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Pharmacokinetics and Safety of Venetoclax in Subjects With Impaired Renal Function

NCT04810598 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT04810598
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04810598 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Pharmacokinetics and Safety of Venetoclax in Subjects With Impaired Renal Function
Lead sponsor
AbbVie
Phase
Phase 1
Overall status
Completed
Start date
July 8, 2021
Completion date
August 16, 2022
Enrollment
12 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

renal disease, renal impairment